Skip to content

Insider · CIK 0001255927

Kania Edwin

Reports to the SEC for 23 companies · ANDOVER, MA

Transactions

50

Companies

23

Filings

10

CIK

0001255927

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-05-20TMDXTransMedics Group, Inc.A Award—
2025-05-22TMDXTransMedics Group, Inc.A Award—
2024-05-23TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award—
2024-05-23TMDXTransMedics Group, Inc.A Award—
2023-05-25TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award—
2023-05-25TMDXTransMedics Group, Inc.A Award—
2023-02-28TMDXTransMedics Group, Inc.J Other+$11.6M
2023-02-28TMDXTransMedics Group, Inc.J Other+$7.73M
2022-06-01TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award—
2021-11-29TMDXTransMedics Group, Inc.P Purchase+$1.68M
2021-11-29TMDXTransMedics Group, Inc.P Purchase+$574K
2021-11-19TMDXTransMedics Group, Inc.J Other—
2021-11-19TMDXTransMedics Group, Inc.J Other—
2021-11-17TMDXTransMedics Group, Inc.G Gift—
2021-11-17TMDXTransMedics Group, Inc.J Other—
2021-11-17TMDXTransMedics Group, Inc.J Other—
2021-11-17TMDXTransMedics Group, Inc.J Other—
2021-05-27TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award—
2020-01-14MRNAModerna, Inc.S Sale−$2.35M
2020-01-10MRNAModerna, Inc.S Sale−$7.27M
2019-12-12TMDXTransMedics Group, Inc.J Other—
2019-12-12TMDXTransMedics Group, Inc.J Other—
2019-12-10MRNAModerna, Inc.S Sale−$1.88M
2019-10-29TMDXTransMedics Group, Inc.J Other—
2019-10-29TMDXTransMedics Group, Inc.J Other—
2019-05-06TMDXTransMedics Group, Inc. · Series C Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series B-1 Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series A-1 Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc.P Purchase+$533K
2019-05-06TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc.C Conversion—
2019-05-06TMDXTransMedics Group, Inc.C Conversion—
2019-05-06TMDXTransMedics Group, Inc.C Conversion—
2019-05-06TMDXTransMedics Group, Inc.J Other—
2019-05-06TMDXTransMedics Group, Inc.J Other—
2019-05-06TMDXTransMedics Group, Inc.J Other—
2019-05-06TMDXTransMedics Group, Inc.J Other—
2019-05-06TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series C Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series B-1 Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series A-1 Convertible Preferred StockC Conversion—
2019-05-06TMDXTransMedics Group, Inc. · Series F Convertible Preferred StockC Conversion—
2017-05-16RNACCartesian Therapeutics, Inc.S Sale−$3.74M
2016-06-27RNACCartesian Therapeutics, Inc. · Series E Convertible Preferred StockC Conversion—
2016-06-27RNACCartesian Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion—
2016-06-27RNACCartesian Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion—
2016-06-27RNACCartesian Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion—
2016-06-27RNACCartesian Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion—
2016-06-27RNACCartesian Therapeutics, Inc.C Conversion—